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CHAPTER I
INTRODUCTION
The purpose of this thesis is to identify rheumatoid factor in the
subgingival plaque, saliva and peripheral blood, of Type III periodontitis patients.
Also, this thesis will discuss the chronic antigenic stimulating
nature of periodontal disease and its possible association with rheumatoid factor; an autoantibody present in diseases of chronic antigenic
stimulation.

{P.M. Johnson, W. Page Faulk, 1976, Ralph C. Williams, Jr.,

1979, James Taborn, Sara E. Walker, 1979)
Furthermore, this thesis may result in the classification of
periodontal disease with other chronic diseases, characterized by chronic
antigenic stimulation which are associated with rheumatoid factor.

1

CHAPTER II
REVIEW OF LITERATURE
Accordingly, the etiologic agent sited in most types of periodontal
disease seems to be microbial.

Genco (1970).

Two possibilities have

been discussed relating to the tissue destructive action of chronic periodontal disease: (1) direct initiation of the inflammatory response by
injurious microbial metabolites and (2) initiation of periodontal inflammation by antigens of oral microorganisms setting immunopathologic
processes into action.

Genco (1970).

For years, researchers have suggested that immunologic mechanisms
may play a role in some form of periodontal disease.
Healy, J.C. and Sweet, M.H. (1936).
and Mandel, I.D. (1963).

Daley, F.H.,

Harkavy, J. (1948).

Ellison, S.A.

It has been shown that the Arthus reaction

Terner, C. (1965) and chronic allergic inflammation Rizzo, A.A. and
Mitchell, C.J. (1966) can induce inflammatory responses in the periodontal unit.
Furthermore, a number of different antigens have been shown to
induce inflammation upon repeated injury to the periodontium of several
species of animals.

Also human studies have shown periodontally diseased

patients can have circulating antibodies specific for oral bacteria.
Nisengard, R., Beutner, E.H. and Hazen, S.P. (1968) have reported
evidence which points to hypersensitivity as an etiologic factor in
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human inflammatory periodontal disease.

Animal tests with a reagent

prepared from actinomyces indicated that it was both reactive and safe
for human use.

Skin tests of humans with this reagent revealed a cor-

relation between the immediate hypersensitivity and the presence of
periodontal disease.
Terner, C. (1965), has shown an active Arthus phenomenon successfully provoked in the tongue, attached gingiva, buccal mucosa of the
rabbit, guinea pig and rat.

In the attached gingiva, atypical reactions

without necrosis occurs as frequently as the typical reaction with necrosis and ulceration.

Lighter animals display the typical reaction in

a significantly higher proportion than heavier ones.
Rizzo, A.A. and Mitchell, C.J. (1966) exposed rabbits repeatedly
to a protein antigen by triweekly insertion of pellets containing egg
albumin (EA) into labial gingival pockets of mandibular incisors.

In

one control group pellets containing saline were inserted in animal pockets.

In rabbits, whose pockets were treated with EA, the gingiva

showed chronic inflammation with numerous plasma cells and sera containing intermediate levels of anti-EA antibody.

In contrast saline treated

rats showed normal histology and their sera did not contain antibody.
Findings seem to indicate that antigen was absorbed into the gingiva and
that it caused both a local and systemic immunologic response.

Their

findings support the concept that the gingival plasmacytosis of chronic
periodontal disease is brought about by local absorption of bacterial
antigens.
Mergenhagen, S.E. and Rizzo, A.A. (1961) injected 1.0 ml of horse
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serum every other day subcutaneously in the intrascapular area of New
Zealand rabbits.

After 3,5, and 6 sensitizing injections - animals were

challenged intramucosally in the gingiva and palatal mucosa.

Rabbits

which were sensitized with as few as three injections over a six day
period showed, mucous with edema and plasma cell infiltration.
sitized animals showed a minimal response.

Nonsen-

Authors concluded allergic

type mechanisms may play an important role in the development of the
pathologic lesion of periodontal disease.
Beutner, E.H., Trifthause, C., Nisengard, R. and Frinnan, A.J.
(1966) sensitized guinea pigs, by systemic immunization with bovine
serum albumin in complete Freunds adjuvant.

Subsequently the animals

were challenged by a intragingival injection with the same antigen.

Fol-

lowing challenge, the teeth had increased mobility, osteoclastic resorption and gingiva appeared inflamed as compared with control animals.

The

pathologic changes observed in the gingiva of sensitized guinea pigs
following gingival challenge with the sensitizing antigen resembles
those seen in inflammatory types of human periodontal disease.
Mergenhagen, S.E., de Arajio, W.C. and Varah, E. (1965) utilizing
a hemolysis

procedure employing soluble antigen extracted from a strain

of Leptotrichia buccalis, showed hemolytic antibody to L. buccalis in
the sera of adult individuals.

This experiment indicated that man may

have the capability of developing antibodies to somatic antigens.
Evans, R.T., Spaeth, S. and Mergenhagen, S.E. (1966) demonstrated
mice immunized intraperitoneally with

r.

alcalescens in complete Freund•s

adjuvant developed high titers of bactericidal antibody in both serum and
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ascitic fluid.

Immunization of rabbits with serum sensitive strains of

V. alcalescens produced high titers of specific bactericidal antibody but
did not affect the levels of this antibody to serum sensitive strains of

f. coli or Salmonella typhosa. Sera from adult patients with periodontal
disease when compared to normal adult sera were found to contain increases in bactericidal antibody to f. polymorphum an organism associated with
periodontitis and Vincent's infection.
The potential for an immunologic mechanism to play a role in periodontal pathology is clear.

Antigens are abundant in dental plaque and

periodontal tissues can exhibit immunologic reactivity, moreover, experimental periodontal disease has been induced in animal systems by
immunologic processes.

Genco (1970).

A commonly found mitogen-antigen in dental plaque has been shown
to be endotoxin, a macromolecular complex of lipopolysaccharide derived
from the outermost membrane of gram negative bacteria.

Simon, B.I.,

Goldman, H.M., Ruben, M.P., Broitman, S., Baker, E. (1972).

Mergenhagen,

W.E., Bladen, H.A. and Hsu, K.C. (1966).
The presence of lipopolysaccharides in dental plaque and periodontal disease has been associated with the pathogenesis of periodontal
disease.

Simon, B., Goldman, H., Ruben, M. and Baker, E.

(1969). Simon,

B., Goldman, H., Ruben, M., Broitman, S., and Baker, E. (1972).
The relationship of endotoxin and the etiology of periodontal
disease becomes of interest when one notes that endotoxin is a potent inflammatory agent.
Bacterial lipopolysaccharides have the capacity to exhibit
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biological effects on the immune system.

Included in these effects are

mitogenicity, a phenomenon restricted to B lymphocyte cell population;
Gery, I., Kruger, J. and Spiessel, S.Z. (1972}, Andersson, J., Moller, G.
and Sjoberg, 0. (1972), adjuvanticity capable of antibody formation Johnson, A.G., Gaines, S. and Landy, M. (1956}, Neter, E. (1969), and high
immunogenic potential, in that low concentrations will cause a specific
antibody response in experimental animals.

Landy, M. and Baker, P.J.

(1966) Nossal, G.J.V. and Ada, G.L. (1971).
Surprisingly LPS has the capability of circumventing thymus derived
T-cell helper function, which otherwise is required for initiation of
antibody response to T-cell dependent antigens.

Schmidtke, J. and Dixon,

F. J. (1972).

The LPS macromolecule has been chemically characterized into three
regions: Luderitz, 0., Westphal, 0., Staub, A.M. and Nikaido, H. (1971).,
(1) the 0 polysaccharide which is linked to (2) the core polysaccharide
which is in turn linked to (3) a lipid A by a trisaccharide of 2-Keto-3deoxyoctanoic acid.

It has been demonstrated the mitogenicity and adju-

vanticity were actions attributed to the lipid region of the molecule;
whereas, the antigenic specificity was related to the polysaccharide
region.

Luderitz, 0., Westphal, 0., Staub, A.M. and Nikaido, H. (1971).

It has been demonstrated that LPS acting independently of antibody
has the capacity to trigger the alternate complement pathway of inflammation.

See figure 1.

Roitt, I.M. and Lehner, T. (1980).

Furthermore, characteristic of some chronic antigenic stimulating
diseases is polyclonal B-cell lymphocyte activation.

Freeman, R.R. and
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Parish, C.R. (1978), found preparations of Plasmodium berghei Kl73 and
Plasmodium yoelii 17X have activity in vivo, and that the treatment in
mice with the mitogenic supernatant results in polyclonal 8 cell activation and non-specific IgM synthesis.
Greenwood, 8.M. (1974), has hypothesized that the increased synthesis of immunoglobulin production seen in patients with African trypanosomiasis could be the consequence of, polyclonal 8-cell lymphocyte activation.
A technique for the detection of polyclonal antibody production has
been demonstrated by Cunningham.
(1968).

Cunningham, A.J. and Szenberg, A.

Mice injected with 8-cell mitogen lipopolysaccharide from Es-

cherichia coli, showed the production of polyclonal 8-cell activation
measured by splenic plaque forming cells (PFC).
Kobayakawa, T., Louis, J., Izui, S. and Lambert, P.H. (1979), confirmed that the injection of Trypanosoma brucei (T. brucei) in mice leads
to a nonspecific polyclonal 8-cell lymphocyte activation.

Their conclu-

sions were based first on the observation that the number of lymphocytes
in the spleens of infected mice increased fifteen times three weeks after
the infection, and secondly, the cells producing antibodies against a
variety of antigens appear in the spleen of infected mice.

Furthermore

these nonspecific PFC responses were composed of only direct PFC, suggesting that the secreted antibodies are of the IgM class.

The data con-

firm the conclusion of Hudson, K.M., Byner, C., Freeman, J. and Terry,
R.J. (1976), when an increase in the backround PFC directed against T.
brucei in lymphoid tissues was demonstrated.
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Kobayakawa further demonstrated that autoantibodies produced during
the course of the parasitic infection, seemed to belong to the IgM class.
Development of these autoantibodies is parallel to the growth of polyclonal antibody production.

These findings suggest the formation of auto-

antibodies could be a consequence of the polyclonal B lymphocyte activation.

Kobayakawa, T., Louis, J., Izui, S. and Lambert, P.H. (1979).
Similar immune reactions have been demonstrated to occur in anti-

genic challenge with bacterial lipopolysaccharides.

Izui, S. (1979)

demonstrated the production of rheumatoid factors (autoantibodies) in
several strains of mice, including athymic nude mice.

Significant IgM-

rheumatoid factor activity was observed in seven eight week old female
mice injected intraperitoneally with 50
murium on days 0,7 and 14.

~g

of LPS from Salmonella typhi-

Concentrations of IgM-RF increased continu-

ously up to day 21, which was seven days after the last injection, but
decreased rapidly after this time.

Matched control mice receiving saline

did not show significant changes in IgM-RF during the same period.

The

ability of LPS to induce IgM-RF was then studied in five other strains
of mice and all responded to LPS injections by forming IgM-RF.
Gargiulo, A.V., Toto, P.D., Gargiulo, A.W. and Robinson, J. (unpublished) demonstrated, by latex slide agglutination, rheumatoid factor
in peripheral blood of nine, 12 week old, male Sprague-Dawley rats.
were injected in the palatal gingiva with 50

~g

from Salmonella typhimurium on day 0,9 and 16.

and 100

~g

Rats

doses of LPS

Non-injected rat and

vehicle control rat (injected with 0.085% sterile saline) demonstrated
no rheumatoid factor in peripheral blood.
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According to Kobayakawa, T., Louis, J., Izui, S. and Lambert, P.H.
(1979), the role of lipid A component of endotoxin in the genesis of
of polyclonal B-cell activation is a possibility.
Morrison, D.C., Betz, S.J. and Jacobs, D.M. (1976), have shown mice
lymphocytes to react mitogenically to the lipid A associated protein in
LPS.
Further evidence by Izui, S. (1979) demonstrates that the active
portion of the LPS molecule that is responsible for the RF induction
appears to be the phospho-lipid fraction containing lipid A; since the
highest levels of RF induced in mice correlated with injection of LPS
that contained the most lipid A per molecule.
Such a correlation has been demonstrated by Chiller, J.M., Skidmore, B.J., Morrison, D.C. and Weigle, W.O. (1973), when induction of
DNA synthesis was measured to show lipid A was mitogenic for bone marrow
derived lymphocytes obtained from spleens of congenitally athymic mice.
Izui, S. (1979).
Lipid A has been shown to be structurally composed of a phosphorylated D-acetyl glucosamine to which fatty acids (lauric, myristic,
palmitic and 3-hydroxy myristic) are ester or amide linked.

Rietschel,

E.T., Gottert, H., Luderitz, 0. and Westphal, 0. (1972) have demonstrated
removal of the ester-linked fatty acids by alkaline hydrolysis does
eliminate the B-cell lymphocyte mitogenic stimulus obtained from the
total molecule.
Since bacterial products, specifically lipopolysaccharides, have
been shown to induce polyclonal 8-cell activation and enhance production
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of IgM rheumatoid factor in chronic antigenic stimulating diseases; a
review of rheumatoid factor and its association in chronic disorders is
necessary.
Meyer, K. (1922) was the first to discover rheumatoid factor (RF),
when he showed sensitized sheep red blood cells were agglutinated by
sera of rheumatoid arthritis patients.

Since, research in the field of

rheumatoid arthritis and diseases of chronic antigenic stimulation associated with rheumatoid factor has been intensely and widely published.
Rheumatoid factors have been demonstrated to be antibodies (autoantibodies) directed against altered or native gamma globulin.

The most

common rheumatoid factor occurs as IgM immunoglobulin, which has specificity for antigenic determinants of the Fe fragment of human or animal
IgG.

Taborn, J.D., and Walker, S.E. (1979).

Williams, R.C. (1979).

Immunoglobulin classes of IgG and IgA may also have specificity for IgG.
Torrigiani, G. and Raitt, I.M. (1967).
Although the detection of rheumatoid factor in the serum may support a diagnosis of human rheumatoid arthritis, its presence may be associated with many other chronic antigenic stimulating diseases.

(See

Table I.)
Rheumatoid factors have a wide range of specificities for IgG.

At

least seven antigenic sites on the IgG molecule react with rheumatoid
factor.

Taborn, J.D. and Walker, S.E. (1979).

Rheumatoid factor reacts

most commonly with antigenic groupings of IgG that have been buried in
the native molecule.

Stage, D.E., and Mannik, M. (l973).The so-called

"hidden determinants" may be revealed by unfolding of the IgG molecule
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TABLE I
CHRONIC ANTIGENIC STIMULATING DISEASES
ASSOCIATED WITH RHEUMATOID FACTOR
Normal persons (2 to 4% of the population)
Rheumatoid arthritis
Relatives of rheumatoid arthritis patients
Aging (10 to 20% positive over age 65)
Systemic lupus erythematosus
Sjogren•s Syndrome
Scleroderma
Dermatomyositis
Sarcoidosis
Leprosy
Dysproteinemias and paraproteinemias
Liver disease (infectious hepatitis, biliary cirrhosis)
Syphilis
Idiopathic pulmonary fibrosis
Pneumoconiosis
Acute pulmonary tuberculosis
Acute viral infections
Parasitic diseases
Following prophylactic vaccinations
Subacute bacterial endocarditis
Diabetes mellitus patients on insulin therapy
Psychiatric disorders (schizophrenia, endogenous depression)
Following multiple blood transfusions
Parenteral narcotic addiction
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in denaturation or by the reaction of IgG with unknown antigen.

Taborn,

J.D. and Walker, S.E. (1979).
The biologic properties of rheumatoid factor is unclear.

Produc-

tion of RF may be caused by an unknown process which changes the patients
IgG and makes it autoimmunogenic.

This process may be a chronic infec-

tion, an acquired abnormality in the IgG causing it to aggregate spontaneously and thereby becoming immunogenic.
(1979).

Taborn, J.D. and Walker, S.E.

There may be an unknown factor in rheumatoid arthritis which

breaks down IgG, thereby forming fragments which stimulate formation of
anti-IgG antibody.

More recently it has been shown in vitro, that B-

cells programmed to synthesize RF are present in both normal and rheumatoid arthritis B-cell lymphocyte repertoires, but are preferentially expressed in rheumatoid arthritis.

Koopman, W.J. and Schrohenloher, R.E.

(1980).
The screening technique most commonly employed to identify the presence of rheumatoid factor is a latex slide agglutination test, first
described by Singer, J.M. and Plotz, C.M. (1956).
The principle of the latex slide agglutination method for the
demonstration of rheumatoid factor involves the use of an indicator system containing a large number of IgG molecules.

The IgG is either bound

to carrier particles, such as latex, bentonite, erythrocytes or the IgG
molecules are simply aggregated by heat denaturation or other means.

The

presence of rheumatoid factor in serum is recognized by agglutination,
precipitation or flocculation of the respective IgG containing indicator
system.

Waller, M.V. and Vaughn, J.H. (1956).

Serial dilutions of the
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serum samples provide an estimate of the quantity of the rheumatoid factor
in terms of titer.
Of course, other methods for the detection of rheumatoid factor are
available.

Radioimmunoassay involves the binding of radioactively la-

belled antigen to a fixed amount of antibody which can be partially inhibited by addition of unlabelled antigen.

The inhibition can then be

used as a measure of the unlabelled material added.

Sato, M., Kasukawa,

R., Murai, T. and Yoshida, T. (1977) have demonstrated the detection of
rheumatoid factors through solid-phase radioimmunoassay.

Rheumatoid

factors of IgG and IgM class were detected by means of solid-phase radioimmunoassay using formalinized sheep erythrocytes sensitized with rabbit
anti-sheep erythrocyte serum and
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I-labelled anti-human IgG or anti-

human IgM antibody.
Another very sensitive and precise method for the detection of
rheumatoid factor is the enzyme linked immunosorbent assay (ELISA).
Voller, A., Bidwell, D. and Bartlett, A. (1977).

The basis of the ELISA

depends on two assumptions: 1) that antigen or antibody can be attached
to a solid-phase support yet retain immunological activity and 2) that
either antigen or antibody can be linked to an enzyme and the complex
retain both immunological and enzymatic activity.

Vejtrop, M., Hoier-

Madsen, M. and Halberg, P. (1979), demonstrated that the ELISA was well
suited for quantitative routine determination of IgM-RF.

Gripenberg, M.,

Wafin, F., Isomaki, H. and Linder, E. (1979), have developed a simple
enzyme linked immunosorbent assay, using human IgG as antigen, and found
good agreement

betw~en

the results and reproducibility.
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Some investigators have suggested a protective role for rheumatoid
factor.

It has been postulated that rheumatoid arthritis has a viral

etiology, and that rheumatoid factor may have antiviral properties in
vitro.

It is thought that viral neutralization may be enhanced by the

addition of human IgG rheumatoid factor.

Interestingly, Ashe, W.K. and

Nothens (1971) have shown the addition of IgM rheumatoid factors facilitates neutralization of virus by antiviral antibody, blocking all antigenic sites in the virus available for cell penetration or fixation.
Rheumatoid factor also influences chemotactic activity and phagocytosis.

The addition of rheumatoid factor, aggregated IgG and comple-

ment to a suspension of neutrophils, produced increased chemotactic
activity compared to aggregated IgG and serum.

Borel, J.F., Sorkin, E.

and Loewi, G. (1971).
However, in another in vitro system phagocytosis of bacteria was
inhibited by rheumatoid factor.

Messner, R.P. (1968).

Further, it was

shown white blood cells which have ingested rheumatoid factor IgG complex
have reduced ability to phagocytose bacteria.
Animal studies have shown, that rheumatoid factor can be induced
with the use of prolonged intravenous hyperimmunization with coliform
bacteria.
globulins.

Christian, C.L. (1963) or immunization with autologous gamma
Catsoubi, E.A. (1965).

Rabbits immunized with autologous gamma globulin produced antigammaglobulin antibody with primary specificity for human rather than
rabbit IgG.

Similarly, injection of a rabbit with autologous immuno-

globulin complexes in complete Freund•s adjuvant stimulated production of
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an anti-gammaglobulin reaction with human IgG and rabbit IgG.

Rabbit

rheumatoid factors react specifically with the Fe fragment of IgG and
pepsin digested IgG.

The above phenomenon was found in serum from rab-

bits receiving long term immunization of cell wall carbohydrate derived
from streptococci.

Osterland, C.K. (1966).

Restifo, R.A. (1965) demonstrated the induction of acute arthritis
by intra-articular injection of autologous IgG in rheumatoid arthritis
patients, who have rheumatoid factor; while the same injection in seronegative rheumatoid arthritic patients did not cause synovitis.

In a

similar study, prolonged intravenous infusion of rheumatoid factor had
no adverse effect on normal subjects.
The proposed mechanism of tissue destruction in rheumatoid arthritis
is the fixation of complement by rheumatoid factor-IgG complex which is
engulfed by polymorphonuclear leukocytes.

The leukocytes then indirectly

release the tissue destroying enzymes.
In Sjogren's Syndrome with or without rheumatoid arthritis, the incidence of serum rheumatoid factor approaches one hundred percent.

Bunim,

J.J., Buchanan, W.W., Wertlake, P.T., Sokoloff, L., Block, K.J., Beck,
J.S. and Alepa, F.B. (1964).

No other population of patients, including

those with rheumatoid arthritis, have such a high frequency of this autoantibody.

Anderson, L.G., Cummings, N.A., Aosfsky, R., Hylton, M.B.,

Tarpley, T.M., Tomasi, T.B., Wolf, R.O., Schall, G.L. and Talal, N. (1972).
In vitro studies utilizing lip biopsy specimens, suggest lymphoid cells
infiltrating the salivary glands in Sjogren's Syndrome, synthesize large
quantities of IgM and IgG, some with an anti IgG or rheumatoid factor
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activity.

Clinically, macroglobulin, a characteristic of Waldenstrom Syn-

drome appears to play a prominent role in the lymphoproliferative process
in some patients with Sjogren's Syndrome.

The above report supports the

coexisting Sjogren's Syndrome and Waldenstrom's macroglobulinemia reported in the literature.

Pinkus, G.S. and Dekker, A. {1970).

White-

house, A.C., Buckley, C.E. III, Nagaya, H. and McCarter, J. (1967).
Malsville, J., Heid, F., Rousselot, P., Bergoend, H., Grosshans, E. and
Araujo, A. ( 1967).
Chronic antigenic stimulation is characteristic of both periodontal
disease and rheumatic diseases.

The method of tissue destruction by poly-

morphonuclear leukocytes associated with both of these chronic disorders
is similar.

Furthermore, the association between rheumatic diseases, dis-

orders of chronic antigenic stimulation, and rheumatoid factor has well
been established in the medical literature.

Is there an association be-

tween periodontal disease, a disease of chronic antigenic stimulation,
and rheumatoid factor?

This is the purpose of the present investigation.

The association of periodontal disease with other diseases of
chronic antigenic stimulation in which polyclonal antibodies are produced
containing rheumatoid factor appears promising.

It is the purpose of

this study to determine the presence of rheumatoid factor in the gingival
crevice of patients with moderate to advanced periodontitis.

CHAPTER III
MATERIALS AND METHODS
Materials
1.

Latex Human IgG Slide Agglutination Test- 11 Rheumanosticon 11 for the
determination of rheumatoid factor, by Organon, West Orange, New
Jersey.
Kit Contents:

2.

a.

Latex reagent-particle size, 0.81 microns

b.

Glycine buffered concentrate (glycine buffered saline)

c.

Positive serum control

d.

Negative serum control

e.

Dispenstirs, designed to deliver 0.03 ml

f.

Black background slide

12 mm x 75 mm sterile polystyrene tubes (Cole Parmer Instrument Company, Chicago, I 1 . )

3.

Disposable 0.5 ml microcentrifuge tubes (Cole Parmer Instrument Company, Chicago, Il.

4.

Centrifuge

5.

Blood lancets (Scientific Products, McGaw Park, Il.)

6.

70% isopropyl alcohol

7.

Non-containing IgG, or blank latex beads, 0.80 microns (Sigma Laboratories, St. Louis, Missouri)
18
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8.

The Colorimetric Determination of Albumin (Sigma Laboratories, St.
Louis, Missouri

Human Subjects:
Thirty Type III Periodontitis patients, selected by using the American
Dental Association Classification for Periodontal disease.
Classification:
Type I

- Gingivitis (shallow pockets, no bone loss)

Type II

- Early periodontitis (moderate pockets,
minor to moderate bone loss,
satisfactory topography, usually no
tooth mobility)

Type III - Moderate periodontitis (moderate to
deep pockets, moderate to severe bone
loss, unsatisfactory bone topography)
Type IV - Advanced periodontitis (deep pockets,
severe bone loss, advanced mobility
patterns, usually missing teeth, may
become prosthetic reconstruction case)
Methods
A.

Subgingival plaque and fluid were tested for rheumatoid factor
as described below:
1.

Subgingival contents were sampled from a periodontal
pocket, 5-6 mm in depth, of a Type III periodontitis
patient, with the use of a sterile curette.
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2.

The subgingival plaque sample was sonicated in 0.18 ml
of glycine buffered slaine (GBS), contained in a
disposable 0.5 ml microcentrifuge tube.

3.

The microcentrifuge tube containing the sonicated
sample was placed in a 12 mm x 75 mm polystyrene tube,
and centrifuged at 3,675 rpm for ten minutes to remove particulate matter.

4.

The initial plaque dilution was heat inactivated at
56°C for thirty minutes, in order to inactivate
complement components.

5.

0.03 ml of the initial dilution was placed on the
black background slide issued in the kit, and
mixed in a figure eight configuration with 0.03 ml
of latex containing -IgG for one minute at room
temperature.

Tests will be scored as positive on

flocculation or negative in the absence of flocculation,
according to the manufacture's direction.

All initial

dilutions yielding a positive test were then diluted
1:20 and retested in the same manner as described
above.

1:20 dilutions were made by pipetting 0.1 ml

of initial plaque dilution and placing it in 1.9 ml of
GBS.
6.

Positive and negative controls accompanied the above
reactions as provided in the test kits.
Positive control - a dilution of human sera
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containing rheumatoid factor
causing flocculation of IgG
adsorbed latex particles.
Negative control - dilution of human sera
containing no detectable
rheumatoid factor, which will not
flocculate latex particles
adsorbed with IgG.
Negative control - latex particles not containing
adsorbed IgG, that is blank particles,
which do not flocculate with sera
with or without rheumatoid factor.
B.

Saliva was tested for rheumatoid factor as described below:
1.

0.25 ml of human saliva was drawn from pooled saliva
from the floor of the mouth.

This sample was placed

in a 0.5 ml microcentrifuge tube.
2.

The saliva sample was heat inactivated at 56°C for
thirty minutes and centrifuged at 3,675 rpm for
ten minutes.

3.

0.03 ml of the centrifuged saliva sample was placed
on the black background slide and assayed with 0.03 ml
of latex containing IgG and mixed in a figure eight
configuration.

Any initial samples yielding a

positive result were diluted 1:10 and re-tested in
the same manner, and examined for evidence of
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flocculation.
4.

Tests were scored as in step 5 of subgingival plaque
testing, and similar controls were utilized as
described in step 6 under subgingival palque testing.

5.

Stimulated pooled saliva was also obtained from ten
full denture patients, wearing full denture prosthesis.
These patients were utilized as controls.

C.

Blood was tested as described below:
1.

The patient•s middle finger was wiped clean with a
70% isopropyl alcohol.

A finger puncture was made

with a blood lancet provided by Scientific-Products.
2.

The blood was not milked from the finger but allowed
to flow, and it was collected in a sterile dispenstir,
provided in the test kits.

0.03 ml of blood was drawn

through the dispenstir, which is approximately equal
to one squeeze of the dispenstir between the thumb and
forefinger.
3.

One free-falling drop was diluted in 0.25 ml of GBS in a
12 mm x 75 mm test tube.

4.

This represents a 1:10 dilution.

0.03 ml of the 1:10 dilution is assayed with 0.03 ml of
IgG containing latex beads on the black background slide
and mixed in a figure eight configuration, and examined
for flocculation.

Any positive tests are further diluted

to 1:20 in GBS and retested for rheumatoid factor.
5.

Scores and controls were made as previously described.
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D.

Albumin concentration control:
A Colorimetric Determination of Albumin (Sigma Labs. St.
Louis, Missouri), was performed on all subgingival plaque
samples to determine albumin concentrations.

In order to

standardize plaque samples through protein concentration,
albumin can serve as an indicator of serum protein component
of gingival plaque and fluid.
In the above colorimetric test, Rodkey (1965) determined
bromocresol green (BCG) will bind to albumin and not to
other proteins.

The intensity of the color of the albumin-

BeG complex is measured at 630± 5nm in a Coleman 6/35
spectrophotometer.
Procedure
1.

Sterile test tubes 12 x 75 mm were labelled, blank, standard,
subgingival plaque 1, subgingival plaque 2 ... subgingival
plaque 30.

2.

To all tubes 5.0 ml Albumin Color Reagent, Stock No. 630-2
was added.

3.

To blank test tubes, 20

~1

of 0.85% sodium chloride solution

was added.
To the standard,

20~1

Protein Standard Solution, Stock No.

540-10 was added.
To each tube labelled subgingival palque, 20

~1

of the sub-

gingival plaque dilution was added.
4.

All tubes were vortexed for thirty seconds and allowed to
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stand at room temperature for 10 min.
5.

Absorbance of blank, standard and subgingival plaque was read
at 630 nm., in a Coleman Spectrophotometer 6/30.

CHAPTER IV
RESULTS
In this investigation, the patient sample size numbered thirty.
There were twenty males and ten females, whose ages ranged from 28-65
years.

The mean age was 45.1 years.
All patients selected for this study were classified as having a

Type III periodontal condition and without history of rheumatic diseases.
Table II describes the results obtained from subgingival plaque in
1.8 ml of GBS, and serum diluted in GBS 1:10 and 1:20, when assayed with
IgG-containing latex beads and blank (non-containing IgG latex beads) as
a parallel control, for the detection of rheumatoid factor.
Negative and positive serum controls all were negative or positive,
respectively.

Of the experimental subjects, 66.6% showed positive agglu-

tinations with bacterial plaque; 83.3% with serum 1:10 and 6.6% with
serum 1 :20.
Table III describes the results obtained from stimulated saliva and
saliva diluted in GBS 1:10, when assayed with IgG-containing latex beads
and blank beads as a parallel control, for the detection of rheumatoid
factor.

Of the experimental subjects 100% of the stimulated undiluted

whole saliva samples were positive for RF but only 40.0% were positive at
1:10 dilution.

Control saliva obtained from ten edentulous denture pa-

tients wearing full denture prosthesis, ranging from 59-88 years of age,
25
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was assayed as described above for the thirty experimental patients.
50% of the stimulated samples were positive for RF; however, at 1:10
dilution only one sample or 10% was positive.
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TABLE II
Positive and Negative Reactions Tabulated
For Detection of Rheumatoid Factor
Patient
No.-Age
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30

-

Subgingival
Serum
plaque/l.88cc 1 :1 0
GBS

31
29
60
46
51
39
51
46
58
32
32
33
33
47
28
33
52
65
37
61
28
65
41
45
31
55
52
63
52
57

+
+
+
+
+
+
+
+
+

Serum
1 :20

Neg.
Cont.

+
+
+
+
+
+
+
+
+

+
+

+
+

+
+
+
+
+
+
+
+

+
+
+
+
+
+

Blank
Beads

+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+

+
+
+
+
+
+
+
+

+
+
+

Pos.
Cont.

No. of
Agglutinations 20

25

2

0

30

0

Percent
Agglutination

83.3%

6.6%

0%

100%

0%

Mean
Standard
Deviation

66.6%
.66

.83

.06

0.0

1.0

0.0

±.47

±.37

±.25

±0.0

±0.0

±0.0
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TABLE III
Positive and Negative Reactions Tabulated
For Detection of Rheumatoid Factor
Patient
No.-Age
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30

-

31
29
60
46
51
39
51
46
58
32
32
33
33
47
28
33
52
65
37
61
28
65
41
45
31
55
52
63
52
57

Stimulated
Saliva

Saliva
1:10

+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+

+

No. of
Agglutinations 30
Percent Positive
Agglutinations 100%
Mean
Standard
Deviation

Negative
Control

Positive
Control

Blank
Beads

+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+

+

+

+

+
+
+
+
+
+
+
+

12

0

3

0

40.0%

0%

100%

0%

1.0

.40

0.0

1.0

0.0

±0

±.49

±0.0

±0.0

±0.0
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TABLE IV
Control Saliva
Ten Full Denture Patients
Patient
No.-Age

Stimulated
Saliva

Saliva
1:10

1 - 88

+

+

2 - 65

+

+

3 - 67

+

+

Negative
Control

Positive
Control
+

4 - 78

+

5 - 59

+

6 - 63

+

7 - 61

+

+

8 - 64

+

+

9 - 66

+

10 - 68

+

No. of
Agglutinations

5

Percent Positive
Agglutinations 50%
Mean
Standard
Deviation

Blank
Beads

1

0

10

0

10%

0%

100%

0%

.50

. 10

0.0

0.0

0.0

±.52

±.31

±0.0

±0.0

±0.0
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Albumin concentration in each subgingival
plaque dilution as determined by the Colorimetric
Determination of Albumin, are listed in Table V.
Concentrations were calculated as follows:
Albumin-subgingival
Absorbance of subgingival
plaque dilution (gm/100 ml) = ~Pl;...::.a:....:~g~..=:u.;;-e.....;d::...:i...:..l..:;.ut..::..i:..::o:..;:n...,..----.--.,...
Absorbance of Standard
albumin
Concentration of the
Standard albumin (gm/100 ml}
For example:

the calculated concentration of albumin
in the subgingival plaque dilution of
patient no. 19, was determined as follows:

Albumin-subgingival
plaque dilution (gm/100 ml)

=

.02
.45

x 5.0 gm/100 ml

= .22 gm/100 ml
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TABLE V
Albumin Concentration Determined by Colormetric Determination of Albumin In Diluted
Subgingival Plaque
Patient No.

1
2
3
4

5
6
7
8
9

10
11

12
13
14

15
16
17

18
19

20
21
22
23
24

25
26
27
28

29

30

Absorbance
subgingival
plaque dil.

Albumin cone.
in subgingival
plaque dil.
(gm/1 OOml)

. 015
.05
.05
. 01
.015
.05
.015
.05
.015
.012
. 01
.05
.012
.01
.08
.013
.016
.015
.02
.018
• 021
.015
.06
.025
.018
. 031
.013
. 01
. 015
.02

Mean albumin concentration = .27 gm/lOOml
Standard deviation = ± .20 gm/lOOml

. 16

.55
.55
.11
. 16

.55
.16

.55
. 16

.13
.11
.55
. 13
.11
.88
. 14
• 17
.16

.22
.20
.23
.16

.66
.27
.20
.34
. 14

.11
. 16

.22

CHAPTER V
DISCUSSION
Diluted subgingival plaque, sera and saliva of patients with Type
III periodontal disease show evidence of rheumatoid factor by the macroscopic agglutination between anti-IgG globulins or rheumatoid factors and
the IgG containing latex beads.
Blank latex beads failed to agglutinate when assayed with subgingival plaque, serum or saliva.

This demonstrates the latex beads themselves

did not non-specifically agglutinate to some moiety present in the test
samples.
Concentration of albumin in diluted subgingival plaque samples
ranges from 0.11 to 0.88 g/lOOm. Mean and standard deviation of albumin
concentration was determined to be 0.27± 0.20 g/100 ml. A significant reduction of albumin in the subgingival plaque samples was evident when
compared to the normal serum albumin levels ranging from 3.8-5.1 g/100 ml.
In this investigation, even though the plaque samples were diluted, reduction of albumin levels in the gingival exudate as compared with serum
levels seems to be in agreement with the findings of Brill and Bronnenstan
(1960) and Schenkein and Genco (1977).

The significance of the presence

of albumin in diluted subgingival plaque samples, indicates the presence
of serum proteins in crevicular fluid.

For example, Shillitoe and Lehner

(1972) have described the concentrations of IgG, IgA, IgM and
32

c3

in
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gingival fluid from periodontally diseased patients to be well below
their respective serum levels.
Furthermore, positive agglutination reactions in subgingival plaque
corresponded to low concentrations of albumin, suggestive of rheumatoid
factor production locally and not from factors entering the gingival crevice from the serum.

See Figure 2.

In eighteen subjects with chronically inflamed gingiva Schenkein
and Genco (1977) have shown IgG, IgM and IgA in decreased concentration
in gingival fluid as compared to serum levels.
Experimental subjects with chronic periodontitis have rheumatoid
factor in their pooled whole saliva.

This may be of positive diagnostic

significance as saliva of edentulous patients are positive only in 50% of
the patients.

Moreover, dilution of control saliva results in only 1 in

10 positive.

Perhaps edentulous patients may have had chronic periodon-

titis prior to full denture prosthesis; and this is the reason for the
residual dilute rheumatoid factor.

Only through additional studies may

this point be answered.
Blank latex beads were unreactive with control saliva; this corresponds well with the results obtained with diluted subgingival plaque.
In analyzing agglutination reactions between plaque samples and
1:10 serum samples, all subjects with periodontitis demonstrating positive reactions in plaque (20 of 30) also showed positive reactions in
1:10 serum except one individual.

This seems interesting, as none of the

subjects with periodontitis had rheumatoid arthritis.

As a serum dilu-

tion of 1:20 demonstrating agglutination is essential in supporting a
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Figure 2
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diagnosis of rheumatic disease.

Substantiating this fact, is the observa-

tion of only two subjects of the experimental group demonstrating positive
agglutinations in serum diluted 1:20.

Therefore, this is evidence that

the periodontal patients in this study did not have rheumatic disease; and
the two subjects with positive sera agglutination at 1:20, probably fall
into the category of normal persons with rheumatoid factor, as described
by Moskovitz (1975).

Perhaps it is possible that agglutinations seen at

1:10 dilution in the absence of rheumatoid arthritis, is due to the presence of rheumatoid factor associated with the generalized chronicity of
antigenic-mitogenic stimulation characteristic of periodontal disease.
The potential etiology of rheumatoid factor production in periodontal disease may possibly be two fold.

First, rheumatoid factor may be

induced by the mitogenicity, adjuvanticity and immunogenicity of gram
negative bacterial lipopolysaccharides.

Chiller, Skidmore, Morrison and

Weigle (1973) have demonstrated the mitogenic effect of lipopolysaccharide
could be related to a particular structural region of the molecule, namely
the lipid A region.

Lipid A has been demonstrated in association with

gram negative bacteria, endotoxin and periodontal disease.

Tanner, Haf-

fer, Brathall, Viscontis and Socransky (1979) have shown the subgingival
microbiota in advanced periodontal disease to be predominated by gram
negative rods.

Slots (1979) determined the microflora of advanced adult

periodontitis was comprised mainly of gram negative anaerobic rods.
Schwartz, Stinson and Parker (1972) have shown endotoxin localized in
crevicular epithelium by autoradiography.

Simon, Goldman, Reuben, Breit-

man and Baker (1972) have shown endotoxin in gingival exudate and with
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increasing severity of gingival lesions associated with an increase in
the numbers of gram negative bacteria.

Endotoxin of gram negative bac-

teria has further been demonstrated in dental plaque by Mergenhagen,
Bladen and Hsu (1966) and root surfaces of periodontally involved teeth
by Jones and O'Leary (1978) and Aleo, DeRenzis, Farber and Varboncouer
(1974).

Therefore, the basis of gram negative bacterial induction of

rheumatoid factor in periodontal disease by lipopolysaccharide appears
substantially evident.

It has been shown by Izui, Eisenberg and Dixon

(1979) that bacteria associated with lipopolysaccharide causing infection
when administered to rats may trigger the production of IgM-rheumatoid
factor.
Secondly, immune complexes demonstrated by Berglund (1971) in periodontitis must be considered as a potential causitive agent of rheumatoid
factor production.

It has been shown that upon antigen combining with

antibody the Fab portions of the molecule assume a 180° angle in respect
to each other.

As the immune complex is formed an alteration in the ter-

tiary structure of the antibody may occur revealing new or buried antigenic determinants in the Fe fragment of the IgG molecule.

Vaughn (1972).

Plasma cells might then produce autoantibodies or rheumatoid factors
against these newly revealed antigenic determinants.

This may be a factor

in periodontitis but additional studies to determine the presence of
Ag-Ab complexes are needed.
Subjects with positive reactions for rheumatoid factor in subgingival plaque samples also demonstrated corresponding positive reactions in
samples of stimulated saliva.

Theoretically, perhaps, chronic antigenic
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stimulating substances, for example, lipopolysaccharides, may travel from
gingival tissue to regional lymph nodes resulting in rheumatoid factor
production by plasma cells in germinal centers.

It has been shown by

Mellors, Nowoslawski and Korngold (1961) that rheumatoid factor is produced in germinal centers of lymph nodes. Rheumatoid factors may then be
transported to salivary gland tissue and secreted with saliva.

Studies,

are needed to determine if lipopolysaccharide is transported from gingiva
to the lymphoid tissues in salivary glands.

In this event, rheumatoid

factor could be locally produced and secreted with saliva; secretory IgM
has been reported in saliva by 8randtzaeg (1966).
The production of rheumatoid factor in periodontitis in the absence
of rheumatoid arthritis possibly could occur, if the patient has genetically programmed 8-cells for rheumatoid factor production.

Rheumatoid

factor can be produced by patients without rheumatoid arthritis as Koopman and Schrohenloher (1980) have shown 8-cells from non-rheumatoid patients, stimulated by poke weed mitogen, were capable of producing IgMrheumatoid factor.
It has been suggested that rheumatoid factors have a protective
role in the body•s defense.

Vaughn (1972) have shown that rheumatoid

factors have the ability to combine with soluble antigen-antibody complexes and thereby render them less soluble and more easily cleared by
the reticuloendothelial system.
The presence of IgM-rheumatoid factor has been reported to inhibit
some in vitro complement dependent systems, and this has given rise to a
concept that rheumatoid factor could be protective, although in vivo
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analogues are lacking, according to Johnson and Faulk (1976).
Supportive evidence of the complement fixing properties of rheumatoid factor is reported by Goodman (1961) and Franklin (1961) who demonstrate an antigenic site on gamma globulin for rheumatoid factor binding;
and Ishizaka, Ishizaka and Sugakara (1962) showing binding sites for complement component c1 ; both sites are located on the Fe fragment of IgG.
Therefore, if rheumatoid factor binds to and occupies the Fe fragment of
IgG, and blocks complement binding site, the rheumatoid factor molecule
must provide the only available site to bind complement, in such case.
Further support of the complement activation by rheumatoid factor
is reported by Ashe and Notkins (1971) who demonstrate enhanced neutralization of herpes simplex virus by rabbit and human antibody complement by
the addition of IgM-rheumatoid factor.

Furthermore, McCormick, Day,

Morris and Hill (1969) showed more exaggerated complement associated lesions of experimental nephrotoxic nephritis induced in vivo, when IgM
rheumatoid factor was present.
Complement activation by either immune complexes or endotoxin
appears to be present in periodontal disease, also.

Schenkein and Genco

(1977) and Attstrom, Laurel, Larsson and Sjoholm (1974) demonstrated a
marked decrease in c3 and c4 levels in gingival fluid as compared to
serum. The above findings are felt to be suggestive of complement activation and consumption during periodontal inflammation.
Similarly, Hedberg (1964) and Pekin and Zvaifler (1964) have shown
reduced complement levels in synovial fluid due to antigen-antibody reactions, in rheumatoid arthritis.
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Tesar and Schmid (1970) have shown IgM rheumatoid factor has the
capability of transforming soluble complexes to complement fixing aggregates, making immune complexes more easily phagocytized.

Therefore,

rheumatoid factor may possibly act as another homeostatic mechanism in
periodontal inflammation and also be partly responsible for complement
activation and consumption.
It is an established phenomena, that rheumatoid factor in serum may
act as a diagnostic and prognostic indicator in rheumatic diseases.

For

example, William and Kunkel (1962) have demonstrated that positive serum
reaction for rheumatoid factor in patients with bacterial endocarditis,
upon cure, revert to negative.
In this investigation, one may raise the question: can rheumatoid
factor be used as an indicator for severity of disease, prognosis and
possible cure? This may only be determined through additional research.
The following theory is based on the role of rheumatoid factor in
the pathogenesis of rheumatoid arthritis described by Taborn and Walker
(1979), and which is modified in relation to the pathogenesis of periodontal disease.

Chronic antigenic stimulating substances, i.e. gram

negative bacteria derived lipopolysaccharides found in crevicular fluid
or gingival tissue stimulate production of antibody.

Antigen-antibody

complexes are formed which may produce alteration in the tertiary
structure of the antibody revealing new antigenic determinants.

Such

antigenic determinants stimulate production of the autoantibody,
rheumatoid factor.
At this point it must be stated that theoretically rheumatoid
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factor production may have at least two origins.

Either the IgG-globulin

becomes immunogenic upon lipopolysaccharide binding as an antigen or
lipopolysaccharides induce rheumatoid factor directly, in genetically
programmed B-cells.

The generation of a population of competent B-cells

can provide the autoantibody or rheumatoid factor to react with IgG
even in the absence of the original antigen, of course, subject to
other immunologic control factors.

One cannot discount the idea of both

mechanisms operating simultaneously.
In periodontitis, if immune complexes bound by rheumatoid factor
form in crevicular fluid, then they may fix and activate complement components thereby attracting polymorphonuclear leukocytes and macrophages.
In the event of chronic antigenic stimulation, lymphocytes and plasma
cells would continue to proliferate as the disease process becomes more
chronic.

In this case, it could explain why rheumatoid factor levels

are sustained in crevicular fluid.
The etiology of rheumatoid factor production in rheumatic diseases
still is unknown, however a number of theories have been postulated.

In

advanced cases of periodontitis, the association of gram negative bacteria and endotoxin found in dental plaque, root surfaces, gingival exudate and gingival tissues; may be implicated as the etiologic agent of
rheumatoid factor production in periodontal disease.

Bacterial lipopoly-

saccharides or endotoxins have been associated with inflammatory periodontal disease as reported by Snyderman, Gewurz and Mergenhagen (1968),
and Snyderman (1972).

CHAPTER VI
SUMMARY
Rheumatoid factor was determined by latex slide agglutination, on
subgingival plaque samples, stimulated pooled saliva and serum of thirty
patients with Type III periodontitis.
Twenty of thirty patients demonstrated positive reactions for
rheumatoid factor in subgingival plaque, diluted in 0.18 ml of GBS.
All thirty patients demonstrated positive reactions for rheumatoid
factor in stimulated saliva.
Five of the ten full denture patients utilized for control saliva
demonstrated positive reactions for rheumatoid factor.
Twenty five of thirty

~xperimental

subjects demonstrated positive

reactions for rheumatoid factor in serum diluted 1:10.
Blank latex beads, utilized as a parallel control were unreactive,
to subgingival plaque, saliva and serum.
Albumin was detected at a mean concentration of .27 g/100 ml.
The etiology of rheumatoid factor and homeostatic mechanism in
association with periodontal diseases are discussed and may be due to
the reported association of gram negative bacterial endotoxin and the
chronic antigenic stimulating nature of periodontal disease.
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CHAPTER VII
CONCLUSIONS
In the light of this investigation, periodontal disease may be
placed in perspective with other chronic antigenic stimulating diseases
associated with rheumatoid factor.
Further investigation dealing with the role and application of
rheumatoid factor in chronic periodontal disease is essential and necessitates additional research.

42

REFERENCES
1.

Aleo, J.J., DeRenzis, F.A., Farber, P.A., Varboncoeur, A.P.: The
Presence and Biologic Activity of Cementum-Bound Endotoxin,
J. Periodont, 45:672, 1974.

2.

Anderson, J., Moller, G. and Sjoberg, 0.:
Synthesis in T and B Lymphocytes,
4:381' 1972.

3.

Anderson, L.G., Cummings, N.A., Asofsky, R., Hylton, M.B., Tarpley,
T.M., Tomasi, T.B., Wolf, R.O., Schall, G.L., and Talal, N.:
Salivary Gland Immunoglobulin and Rheumatoid Factor Synthesis
in Sjogren's Syndrome, Am. J. Med., 53:456-463, 1972.

4.

Ashe, W.K., and Nothens, T.: Interactions of Rheumatoid Factor With
Infectious Herpes Simplex Virus-Antibody Complexes, Science,
172:176, 1971.

5.

Attstrom, R., Laurel, A., Larsson, U., and Sjoholm, A.,: Complement
Factors in Gingival Crevice Material From Healthy and Inflamed
Gingiva in Humans, J. Periodont Res., 10:19, 1974.

6.

Berglund, S.E.,: Immunoglobulins in Human Gingiva With Specificity
for Oral Bacteria, J. Periodont, 42:546, 1971.

7.

Beutner, E.H., Triftshauer, C., Nisengard, R., and Drinnan, A.J. ,:
Gingival Hypersentitivity Reactions. An Experimental Model
for the Study of Periodontal Diseases. IADR Abstr. #327,
pp. 120, March 1966.

8.

Borel, J.F., Sorkin, E., Loewi, G.,: Neutrophil Chemotaxis Mediated
Rheumatoid Factor, Immunology, 21:165, 1971.

9.

Brandtzaeg, P., Fjellanger, I. and Gjeruldsen, S.T.: Human Secretory
Immunoglobulins. I. Salivary Secretions From Individuals
With Normal or Low Levels of Serum Immunoglobulins, Scand.
J. Haem. Suppl. 12:58, 1970.

10.

Brill, N., Bronnenstan, R.: Immunoelectrophoresis Study of Tissue
Fluid From Gingival Pockets, Acta. Odont. Scand., 18:95-100,
1960.

11.

Bunim, J.J., Buchanan, W.W., Westlake, P.T., Sokoloff, L., Block, K.J.,
Beck, J.S. and Alepa, F.B.: Clinical, Pathologic, and Serologic Studies in Sjogren's Syndrome. Combined Clinical Staff
Conference at the National Institute of Health. Ann. Intern.
Med., 61:509, 1964
43

Selective Induction of DNA
Cellular Immunology,

44
12.

Catsoubi, E.A.: Gamma Globulin Metabolism in Rabbits Immunized With
Autologous Denatured Gamma Globulin, Arthritis and Rheumatism 8:28-49, 1965.

13.

Chiller, J.M., Skidmore, BlJ., Morrison, D.C., and Weigle, W.O.:
Relationship of the Structure of Bacterial Lipopolysaccharides
to Its Function in Mitogenesis and Adjuvanticity. Proc. Nat.
Acad. Sci., 70:2129, July 1973.

14.

Christian, C.L.: Rheumatoid Factor Properties of Hyperimmune Rabbit
Sera, J. Exp. Med. 118:827-844, 1963.

15.

Cunningham, A.J., and Szenberg, A.: Further Improvements in Plaque
Techniques for Detecting Single Antibody-Forming Cells,
Immuno 1ogy, 14:599, 1968.

16.

Ellison, S.A. and Mandel, I.D.:
of Periodontal Disease,

17.

Evans, R.T., Spaeth, S. and Mergenhagen, S.E.: Bactericidal Antibody
in Mammaliam Serum to Obligatorily Anaerobic Gram Negative
Bacteria. J. Immunol. 97:112, 1966.

18.

Franklin, E.C.: The Interaction of Rheumatoid Factors and Gamma
Globulins. Minerva Med. 2:804, 1961.

19.

Freeman, R.R., and Parish, C.R.: Polyclonal B-Cell Activation During
Rodent Malarial Infections, Clin. Exp. Immunol. 32:41, 1978.

20.

Gargiulo, A.V., Toto, P.D., Gargiulo, A.W. and Robinson, J.: Induction of Rheumatoid Factor in Sprague Dawley Rats, 1981
(unpublished).

21.

Genco, R.J.: Immunoglobulins and Periodontal Disease,
41 : 196' 1970.

22.

Gery, I., Kruger, J. and Spiesel, S.Z.: Stimulation of B-Lymphocytes
by Endotoxin, J. Immunology, 108:1088, 1972

23.

Goodman, J.W.: Reaction of Rheumatoid Sera With Fragments of PapainDigested Rabbit Gamma Globulin, Proc. Soc. Exp. Biol. Med.,
106:822-825.

24.

Greenwood, B.M.: Possible Role of a B-Cell Mitogen in Hypergammaglobulinemia in Malaria and Trypanosomiasis, Lancet, i, p.435,
1974.

25.

Gripenberg, M., Warfin, F., Isomaki, H., Linder, E.: A Simple Enzyme
Immunoassay For The Demarcation of Rheumatoid Factor, J.
Immuno. Methods, 31:109, 1979.

Serologic Measures in the Prevention
J. Dent. Res., 42:502, 1963.

J. Periodont.,

45
26.

Harkavy, J.: Manifestations of Allergy in the Oral Cavity,
York Dental Journal, 14:149, 1948.

New

27.

Hedberg, A.: The Depressed Synovial Complement Activity in Adult
and Juvenile Rheumatoid Arthritis, Acta Rheum. Scand.,
l 0: l 09 ' l 964.

28.

Hudson, K.M., Byner, C., Freeman, J. and Tery, R.J.: Immunodepression, High IgM Levels and Evasion of the Immune Response in
Murine Trypanosomiasis, Nature, 264:256, 1976.

29.

Ishizaka, K., Ishizaka, T. and Sugahara: Biological Activity of
Soluble Antigen Antibody Complexes. VII. Roles of An
Antibody Fragment in the Induction of Biological Activities,
J. Immuno l , 88:690-701 , 1962.

30.

Johnson, A.G., Gaines, S. and Landy, M.: Studies on the 0 Antigen
of Salmonella to Protein Antigens by the Purified Lipopolysaccharide. J. Exp. Med. 103:225, 1956.

31.

Johnson, P.M., Faulk, W.: A Review- Rheumatoid Factor: Its Nature,
Specificity and Production in Rheumatoid Arthritis, Clinical
Immunology, and Immunopathology, 6:414-430, 1976.

32.

Jones, W.A., O'Leary, T.J.: The Effectiveness of In Vitro Root
Planing in Removing Bacterial Endotoxin From the Roots of
Periodontally Involved Teeth. J. Periodont., 49:337, 1978.

33.

Kobayakawa, T., Louis, J., Izui, S., and Lambert, P.H.: Autoimmune
Response To DNA, Red Blood Cells and Thymocyte Antigens in
Association With Polyclonal Antibody Synthesis During Experimental African Trypanosomiasis, J. Immunol. 122:296,
1979.

34.

Koopman, W.J., Schrohenloher, R.E.: Enhanced In Vitro Synthesis of
IgM Rheumatoid Factor in Rheumatoid Arthritis, Arthritis and
Rheumatism, 23:985, 1980.

35.

Landy, M. and Baker, P.J.: Cytodynamics of the Distinctive Immune
Response Produced in Regional Lymph Nodes by Salmonella
Somatic Polysaccharide, J. Immunology, 97:670, 1966.

36.

Luderitz, 0., Westphal, 0., Staub, A.M., and Nidaido, H.: in Microbial Toxins, eds. Weinbaum, G., Kadin, S. and Ajl, S.J.,
(Academic Press, New York) pp. 145, 1971.

37.

Maleville, J., Heid, F., Rousselot, P., Bergoend, H., Grosshans, E.,
Araujo, A.: Purpura Dysglobulinemique et Syndrome de
Gourgerot-Sjogrens, Bull Soc. Franc Derm Syph., 74:696, 1967.

46
38.

McCormick, J.N., Day, J., Morris, C.J., and Hill, A.: The potentiating Effect of Rheumatoid Arthritis Serum in the Immediate
Phase of Nephrotoxic Nephritis, Cl in. Exp. Immuno 1 . ,
4:17-28,1969.

39.

Mergenhagen, S.E., Bladen, H.A., Hsu, K.C.: Electron Microscopic
Localization of Endotoxic Lipopolysaccharide in Gram Negative
Organisms, Ann. NY Acad. Sci., 133:279-291, 1966.

40.

Mergenhagen, S.E., DeAraujo, W.C. and Varah, E.: Antibody to
Leptotrichia Buccalis in Human Serum. Arch Oral Biol.,
10:29' 1965.

41.

Mergenhagen, S.E., and Rizzo, A.A.: Allergic Response of Oral
Mucosa to Foreign Protein, J. Dent. Res., 40:695, 1961.

42.

Messner, R.P.: Serum Opsonin, Bacteria and Polymorphonuclear Leukocyte Interaction in Subacute Bacterial Endocarditis,
J. Clin. Invest, 47:1109-1120.

43.

Meyer, K.: Uber Hamagglutininvermehrung und Hamagglutination for
dende, Exp. Ther. 34:229, 1922.

44.

Morrison, D.C., Bety, S.J. and Jacobs, D.M.: Isolation of a Lipid
A Bound Polypeptide Responsible for 11 LPS-inactivated 11
Mitogenesis of C3H/HeJ Spleen Cells. J. Exp. Med. 144:840,
1976.

45.

Moskovitz, R.W.: Clinical Rheumatology: A Problem Oriented Approach
to Diagnosis and Treatment, pp. 24-25, Philadelphia, Lea
Febiger Co., 1975.

46.

Neter, E.: Current Topics in Microbiology and Immunology, (SpringerVerlag, Berlin), 47:92, 1969.

47.

Nisengard, R., Beutner, E. H., and Hazen, S.P.: Immunologic Studies
of Periodontal Disease. J. Periodont, 39:329, 1968.

48.

Nossal, G., Ada, G.: in Antigen, Lymphoid Cells and the Immune
Response, eds. Dixon, F.J. and Kunkel, H. G., (Academic
Press, New York) pp. 245-246, 1971.

49.

Osterland, C.K.: Characteristics of Streptococcal Group-Specific
Antibody Isolated From Hyperimmune Rabbits, J. Exp. Med.
123:599-614, 1966.

50.

Daley, F.H., Healy, J.C. and Sweet, M.H.: Bacterial Allergy in
Relation to Parodontal Disease. Int. J. Orthodont.
22: 1078, 1936.

47
51.

Pekin, T.J. and Zvaifler, N.J.: Hemolytic Complement in Synovial
Fluid, J. Clin. Invest. 43: 1372' 1964.

52.

Pinkus, G.S., Dekker, A.: Benign Lymphoepithelial Lesion of the
Parotid Glands Associated With Reticulum Cell Sarcoma,
Cancer, 25:121, 1970.

53.

Restifo, R.A.: Studies on the Pathogenesis of Rheumatoid Joint inflammation III. Ann. Intern Med. 62:285, 1965.

54.

Rietschel, E.T., Gottert, H., Luderitz, 0. and Westphal, 0.:
Nature and Linkages of the Fatty Acids Present in the LipidA Component of Salmonella Lipopolysaccharides, Eur. J.
Biochem, 28:166, 1972.

55.

Rizzo, A.A., and Mitchell, C.J.: Chronic Allergic Inflammation
Induced by Repeated Deposition of Antigen in Rabbit Gingival
Pockets. Periodontics, 4:5, 1966.

56.

Rodkey, F.L.: Direct Spectrophotometric Determination of Albumin in
Human Serum. Clin. Chern. 11:478, 1965.

57.

Raitt, I.M. and Lehner, T.: in Interaction of Antigen and Antibody
in Vitro, (Blackwell Publications, Oxford) pp. 143, 1980.

58.

Sato, M., Kasukawa, R., Murai, T., Yoshida, T.: A Solid Phase Radioimmunoassay for IgG and IgM Anti-gammaglobulin Factor in
Rheumatoid Arthritis Sera. Int. Archs. Allergy appl. Immunol.
55:70-77, (1977).

59.

Schenkein, H.A. and Genco, R.J.: Gingival Fluid and Serum in Periodontal Diseases. I. Quantitative Study of Immunoglobulins,
Complement Components and Other Plasma Proteins. J. Periodont.
48:772-777, 1977.

60.

Shillitoe, E.J. and Lehner, T.: Immunoglobulins and Complement in
Crevicular Fluid, Serum and Saliva in Man. Arch. Oral Biol.
17:241-247, 1972.

61.

Schmidtke, J. and Dixon, F.J.: Immune Response to a Hapten Coupled
to a Non-Immunogenic Carrier. Influence of Lipopolysaccharide.
J. Exp. Med. 136:392, 1972.

62.

Simon, B., Goldman, H., Ruben, M. and Baker, E.: The Role of Endotoxin in Periodontal Disease. I. A Reproducible Quantitative
Method for Determining the Amount of Endotoxin in Human
Gingival Exudate. J. Periodont. 40:695, 1969.

48
63.

Simon, B., Goldman, H., Ruben, M., Breitman, S. and Baker, E.:
The Role of Endotoxin in Periodontal Disease. IV. Bacteriologic Analyses of Human Gingival Exudate as Related to the
Quantity of Endotoxin and Clinical Degree of Inflammation.
J. Periodont. 43:468, 1972.

64.

Singer, J.M. and Plotz, C.M.: The Latex Fixation Test, I. Application to the Serologic Diagnosis of Rheumatoid Arthritis,
Am. J. of Med. 4:888, 1956.

65.

Slots, Jorgen: Subgingival Microflora and Periodontal Disease.
J. Clin. Periodont. 6:351-382, 1979.

66.

Snyderman, R., Gewurz, H. and Mergenhagen, S.E.: Interactions of
the Complement System With Endotoxic Lipopolysaccharides:
Generation of a Factor Chemotactic for Polymorphonuclear
Leukocytes. J. Exp. Med. 128:259-275, 1968.

67.

Snyderman, R.: Role for Endotoxin and Complement in Periodontal
Tissue Destruction. J.D.R. 51:356-361, Supp. #2, 1972.

68.

Stage, D.E. and Mannik, M.: Rheumatoid Factors in Rheumatoid
Arthritis. Bull. Rheum. Dis. 23:720-725, 1973.

69.

Taborn, J.D. and Walker, S.E.: Rheumatoid Factor:
American Society of Clinical Pathologists.

70.

Tanner, A., Haffer, C., Bratthall, G.T., Viscontis, N. and Socransky,
S.: A Study of the Bacteria Associated With Advancing
Periodontitis in Man. J. Clin. Periodont. 6:278-307, 1979.

71.

Terner, C.: Arthus Reaction in the Oral Cavity of Laboratory Animals.
Periodontics, 3:18, 1965.

72.

Tesar, J.T. and Schmid, F.A.: Conversions of Soluble Immune Complexes Into Complement Fixing Aggregates by IgM-Rheumatoid
Factor. J. Immunol. 105:1206, 1970.

73.

Torrigiani, G. and Raitt, I.M.: Antiglobulin Factors in Sera From
Patients with Rheumatoid Arthritis and Normal Subjects. Ann
Rheum. Dis. 26:334-340, 1967.

74.

Vaughn, J.H.: in Arthritis and Allied Conditions. Hollander and
McCarty, Jr. (lea &Feb1ger) 1972, pp. 153-171.

75.

Vejtorp, M., Hoier-Madsen, M. and Halberg, P.: Enzyme Linked Immunosorbent Assay for Determination of IgM Rheumatoid Factor.
Scand. J. Rheum. 8:65-70, 1979.

A Review,
10:392, 1979.

49
76.

Voller, A., Bidwell, D. and Bartlett, A.: in Manual of Clinical
Immunology, Rose, N.R., Friedman, H., p. 506-512, 1976.

77.

Waller, M.V. and Vaughn, J.H.: Use of Anti-Rh Serum for Demonstrating
Agglutination Activating Factor in Rheumatoid Arthritis.
Proc. Soc. Exp. Biol. Med., 92:198, 1956.

78.

Whitehouse, A.C., Buckley, C.E. II, Nagaya, H. and McCarter, J.:
Macroglobulinemia and Vasculitis in Sjogren•s Syndrome.
Experimental Observation Relating to Pathogenesis, Amer. J.
Med. 43:609, 1967.

79.

Williams, R.C. and Kunkel, H.G.: Rheumatoid Factor, Complement
and Conglutinin Aberrations in Patients With Subacute
Bacterial Endocardititis. J. Clin. Invest., 41:666, 1962.

80.

Williams, R.C.: A Second Look at Rheumatoid Factor and Other
11
Autoantibodies. 11 , Am. J. of Med. 67:179, 1979.

APPROVAL SHEET
The thesis submitted by Alphonse V. Gargiulo, Jr. D.D.S. has been
read and approved by the following committee:
Dr. Patrick D. Toto, Director
Professor and Chairman, Pathology,
Loyola University Dental School
Dr. Anthony W. Gargiulo
Professor and Chairman,
Loyola University Dental School
Dr. John Robinson
Chief of Clinical Immunology and Rheumatology
Loyola University Medical School
The final copies have been examined by the director of the
thesis and the signature which appears below verifies the
fact that any necessary changes have been incorporated and
that the thesis is now given final approval by the Committee
with reference to content and form.
The thesis is therefore accepted in partial fulfillment of
the requirements for the degree of Master of Science in
Oral Biology.

'ttf~tor~Signature

